These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8153674)

  • 1. Use of recombinant human erythropoietin to treat the anemia of myelodysplastic syndromes.
    Greenberg PL
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):22-4. PubMed ID: 8153674
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin at high dose is effective for the treatment of the anemia of myelodysplastic syndromes.
    Laporte JP; Isnard F; Fenaux P; Woler M; Najman A
    Contrib Nephrol; 1991; 88():271-2; discussion 273-5. PubMed ID: 2040189
    [No Abstract]   [Full Text] [Related]  

  • 3. [Phase II clinical study of recombinant human erythropoietin on the anemia of myelodysplastic syndrome].
    Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
    Rinsho Ketsueki; 1993 Aug; 34(8):928-36. PubMed ID: 8411647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of anemia with erythroid stimulating agents in myelodysplastic syndromes.
    Della Porta MG
    Leuk Res; 2011 Jan; 35(1):22-3. PubMed ID: 20727588
    [No Abstract]   [Full Text] [Related]  

  • 5. The management of anemia in the myelodysplastic syndrome.
    Hamblin TJ
    Leuk Res; 2005 Oct; 29(10):1101-2. PubMed ID: 16111528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use of erythropoietic stimulating agents in myelodysplastic syndromes.
    Santini V
    Oncologist; 2011; 16 Suppl 3():35-42. PubMed ID: 21930833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of recombinant human erythropoietin (rhuEPO) in treatment of anemia in patients with myelodysplastic syndrome].
    Wiecek A; Chudek J; Nieszporek T; Kokot F
    Pol Arch Med Wewn; 1992 Dec; 88(6):451-7. PubMed ID: 1300567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of anaemia with rHuEpo in patients with MDS.
    Casadevall N
    Med Oncol; 1998 Aug; 15 Suppl 1():S35-7. PubMed ID: 9785335
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
    Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human recombinant erythropoietin in the treatment of the anemia of multiple myeloma].
    Valladares Ayerbes MJ; Valenzuela Claros JC; Reina Zoilo JJ; Ruiz Borrego M; Moreno Nogueira JA
    An Med Interna; 1997 Nov; 14(11):593-4. PubMed ID: 9445590
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of recombinant human erythropoietin therapy in myelodysplastic syndromes.
    Adamson JW; Schuster M; Allen S; Haley NR
    Acta Haematol; 1992; 87 Suppl 1():20-4. PubMed ID: 1574963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophilic panniculitis associated with myelodysplastic syndrome with abnormal nuclear forms.
    Becherer K; Golda N; Feldman M; Diaz-Arias A; Caldwell C
    J Cutan Pathol; 2009 Sep; 36(9):1024-6. PubMed ID: 19674208
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recombinant human erythropoietin in the treatment of the anemia of gynecological tumor patients].
    Kurata H; Yoshiya N; Higashino M; Igarashi H; Kaneko T; Kodama S; Tanaka K
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2243-5. PubMed ID: 8239694
    [No Abstract]   [Full Text] [Related]  

  • 14. Durable response to recombinant human erythropoietin in a patient with myelodysplastic syndrome.
    Pedrotti C
    Haematologica; 1996; 81(6):591. PubMed ID: 9009449
    [No Abstract]   [Full Text] [Related]  

  • 15. Serial estimation of serum interleukin 6 during treatment with recombinant human erythropoietin in patients with the anemia of rheumatoid arthritis.
    Jongen-Lavrencic M; Swaak AJ; Vreugdenhil G
    J Rheumatol; 1993 Jul; 20(7):1253-5. PubMed ID: 8371234
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic anemia after lung transplantation: treatment with human recombinant erythropoietin.
    End A; Ringl H; Grimm M; Schlick W; Schreiner W; Klepetko W; Wolner E
    Transplantation; 1994 Apr; 57(7):1142. PubMed ID: 8165717
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of erythropoietin and thalidomide for the treatment of anemia in patients with myelodysplastic syndromes.
    Musto P; Falcone A; Sanpaolo G; Bodenizza C
    Leuk Res; 2006 Apr; 30(4):385-8. PubMed ID: 16219350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin therapy. Part I: clinical issues.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):1-34. PubMed ID: 2928605
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoietin and the myelodysplastic syndrome.
    Jacobs A; Culligan D; Bowen D
    Contrib Nephrol; 1991; 88():266-70. PubMed ID: 2040188
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythropoietin in myelodysplastic syndromes: durable response in a young patient.
    Aloe Spiriti MA; Latagliata R; Petti MC
    Haematologica; 1996; 81(4):381-2. PubMed ID: 8870388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.